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ABSTRACT

ARTICLE HISTORY

Background: The novel Coronavirus disease 2019 (COVID-19) pandemic is already wreaking
havoc on families and communities’ welfare. It is critical to discuss newborn care of infected
mothers with COVID-19 based on the latest international guidelines and national guidelines of
countries with the highest incidence of COVID-19 cases.
Objective: We discuss how to care for a newborn of a suspected or infected mother with
COVID-19 using existing evidence.
Method: As of 16 April 2020, we reviewed articles and guidelines related to COVID-19 in the
reproductive health field, mother, and newborn health. Our review yielded in 10 categories (i)
the risk of diagnostic procedures in suspected mothers on fetus/infant health, (ii) the risk of
intrauterine or postpartum transmission to the fetus/infant, (iii) appropriate method and delivery
time in women with confirmed COVID-19, (iv) umbilical cord clamping and skin to skin contact,
(v) clinical manifestations of infected infants, (vi) confirmation of infection in a suspected neonate/infant, (vii) instructions for infant’s care and how to feed her/him, (viii) bathing the baby,
(ix) the criteria of discharging baby from the hospital, (x) the impact of isolation on the maternal
mental health.
Results: Our findings showed that the possibility of intrauterine or perinatal transmission of
COVID-19 is still questionable and ambiguous. However, what has been agreed upon in the
existing texts and guidelines is that the close contact of mother and infant after birth can transmit the virus to the baby through droplets or micro-droplets.
Conclusions: Based on our findings, it is recommended to separate the baby from the mother
with confirmed (or suspected) COVID-19 infection for at least 2 weeks. Since the motivation and
stable situation of mothers allow breastfeeding during the isolation, infected mothers should be
taught about breast expression skills, common breast problems, the symptoms of their baby’s
infection, and the principles of personal hygiene to protect the infant against COVID19 infection.
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Introduction
The novel Coronavirus disease 2019 (COVID-19) caused
by severe acute respiratory syndrome Coronavirus 2
(SARS-CoV-2) has spread exponentially across the
globe [1]. COVID-19 pandemic has posed critical challenges for public health, research, and medical communities worldwide. The SARS-CoV-2 spreads through
saliva droplets or nasal secretions when an infected
person coughs or sneezes [1], with existing evidence
suggesting that the potential route of spreading
through microdroplets released when talking [2].
These microdroplets can remain 20 min or more in
stagnant air, thus maintaining social distance, wearing
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appropriate masks and air circulation may help mitigate the infection risk [2]. The vast majority of patients
have mild or moderate symptoms and recover without
the need for special treatment, but people with underlying conditions such as diabetes, chronic obstructive
pulmonary disease (COPD), or cancer are more likely
to develop a serious illness [1].
According to the World Health Organization (WHO),
as of 27 May 2020, more than 5 million confirmed
cases were reported globally with >340,000 deaths,
mostly from the United States of America (USA) [1]. In
the Eastern Mediterranean Region, Iran is considered
as an epicenter of COVID-19 with the incidence of
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140,000 confirmed cases with a death toll of 7508 as
of 27 May 2020 [3].
According to a systematic review, COVID-19 may
affect 1% to 5% of children [4] with more likely to present a mild or asymptomatic condition than adults
[5–7]. Evidence shows that COVID-19 occurs in children with rapid recovery much shorter incubation
period [8], and better disease prognosis compared to
adults [9]. Children can be potential and silent carriers
of the virus persistently because they can pass it
through the stool even two weeks after improving
respiratory symptoms [6]. That’s why Xing et al.
warned about the spreading of the infection among
children after reopening of kindergartens and
schools [6].
During the COVID-19 pandemic, pregnant women
and newborns represent a vulnerable population [10].
To date, although there is no strong evidence-based
information showing if pregnant women have a
greater chance of getting sick from COVID-19 than the
general public [8,11–13], it is well established that
pregnant women are at greater risk for severe illness
with viruses from the same family as COVID-19 and
other viral respiratory infections, such as influenza
[14]. Additionally, some experts believe that the
reported cases thus far are too limited to be convincing about virulence of COVID-19 infection among this
population [15]. For example, in a study of 31 pregnant women, Yin et al. found that pregnant women
were more likely to have severe and critical forms of
COVID-19 [16]. Other studies, on the other hand, have
reported the similar severity of the disease in pregnant
and non-pregnant women [8,11–13].
Among this population, cardiopulmonary adaptive
alters present during pregnancy (e.g. elevated heart
rate and stroke volume, and reduced pulmonary
residual capacity) which may increase the risk of hypoxemia and contribute to the increased severity [14].
Thus, health care providers should consider pregnant
women and their infants as a high-risk population in
control and prevention strategies during pulmonaryassociated pandemics like COVID-19 [11,17–20]. One
of the main concerns associated with COVID-19 is the
potential impact on the newborn and its detrimental
consequences [17]. Concerns about how to care for a
baby after birth, such as breastfeeding, vaccination, or
neonatal screening, are among the major concerns of
mothers during COVID-19 pandemic [21].
Maternal-neonatal transmission of respiratory
viruses occurs mainly through close contact, transmission through droplets (caregivers, family members,
and family visitors), hospital-acquired infections, and

exposure to sources of infection from public places
[22]. Currently, it is unclear if COVID-19 can cross
through the transplacental route to the fetus. In limited case series reported to date, no evidence of virus
has been found in the breast milk of women infected
with COVID-19 that can be transmitted through breast
milk (i.e. presence of SARS-CoV-2 in the breast milk)
[23]. Similar to their mothers, newborns appear to be
a high-risk population against COVID-19 infection due
to weakened immune systems [24]. Additionally,
potential
transmission
of
SARS-CoV-2infectious
between infected newborns raises another concern
during this pandemic [8].
The National Health Commission of China (2020)
also recommended postponing the routine follow-up
visits of infants during strict quarantine in early
February. They installed an app on parents’ smartphones and asked them to monitor their baby’s skin
bilirubin [25].
In Iran, pediatricians from Research Institute for
Children’s Health have developed an algorithm based
on diagnostic and therapeutic standards to treat children who are suspected of having COVID-19 infection
(children who have a dry cough, fever, with or without
fever [26]. There are no accurate statistics on the number of infants infected with the COVID-19 infection in
Iran and beyond, but given that COVID-19 is more
contagious than Severe Acute Respiratory Syndrome
(SARS) and Middle East Respiratory Syndrome (MERS)
[18], infants are not immune to the infection and they
are at greater risk of being infected by their parents
or caregivers. It seems that designing such an algorithm and strategies for newborns can be very useful.
Herein, we discuss how to care for a newborn of a
suspected or infected mother with COVID-19 using
existing evidence.

Search method
A systematic search of the literature that was published from 1 January 2020, up through to 30 March
2020, was carried out using two electronic databases
including PubMed and Google Scholar. Additionally,
we searched for statements or guidelines from the US
Center for Disease Control and Prevention (CDC) and
WHO. The search was updated on April 14, 2020. The
search was based on keywords taken from the Mesh
system, including COVID-19 and pregnancy; SARS-CoV2 and pregnancy; Coronavirus and pregnancy; 2019nCoV and pregnancy; and then COVID-19 all and its
equivalents with breastfeeding, neonatal care and
newborn such as COVID-19 and breastfeeding; SARS-
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CoV-2 and neonatal care; Figure 1 and newborn.
COVID-19 and neonatal care and so on.
As shown in flowchart 1, during this period, of the
1,461 articles related to COVID-19 extracted from our
search databases and gray literature, 57 articles were
eligible since they were about COVID-19 and reproductive health. One article was deleted due to the
French language [27]. We reviewed only the abstract
section of papers because their full text was in the
Chinese language [28–30]. One paper was deleted in
this level because it was written entirely in the
Chinese language [31]. We also reviewed gray papers
by searching medRxiv and letters to editors.

Results
The risk of diagnostic procedures in suspected
mothers on fetus/infant health
The computed tomography (CT) images have shown
higher sensitivity in detecting the possibility of viral
pneumonia caused by SARS-CoV-2. This diagnostic
procedure has been used in pregnant women who are
suspected of COVIID-19 infection [12]. Hence, among
afflicted mothers, anxiety about the effect of COVID-19
on their child begins from the fetal period of their
children because mothers worried about the detrimental effects of radiation on their fetus’s health.
According to data from the American College of
Radiology and the American College of Obstetricians
and Gynecologists [17], when a single chest CT scan is
performed for suspected mothers, the radiation dose
to the fetus is only between 0.01 and 0.66 mGy which
is negligible, while harmful effects of radiation such as
microcephaly, fetal growth restriction and cognitive
impairment on the fetus/infant were observed with
doses higher than 610 mGy. Therefore, pregnant
women should be reassured that diagnostic procedures will not harm their fetus/infant.

Risk of intrauterine or postpartum transmission to
the fetus/infant
Regarding the effect of maternal infection on fetal
health, Chen et al. studied 9 pregnant women with
pneumonia caused by COVID-19 and they did not find
any fetal death, neonatal death, or birth asphyxia. The
neonatal Apgar score was normal. Amniotic fluid,
umbilical cord blood, throat swab, and breast milk
were examined in six of these nine cases, which were
reported negative for the SARS-CoV-2 [12].
Fan et al. [32], examined the placenta, umbilical
cord blood, amniotic fluid, and breast milk of two
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physicians with COVID-19. They did not detect SARSCoV-2 in these products. One infant developed mild
fever and lymphopenia, three days after birth. On day
four, diffuse haziness was seen in both lungs of the
baby, but no patchy consolidation was observed on
CT images. The baby responded to antibiotic treatment and was discharged from the hospital on day 8.
In the second baby, only mild pneumonia and lymphopenia were seen, which responded to antibiotics
in two days. In successive follow-ups no traces of
SARS-CoV-2were found in breast milk. The researchers
concluded that both cases showed a low risk of intrauterine and vertical transmissions, but every baby may
be at high risk of transmitting the virus from mother
to child after birth [32]. Wang et al. also did not find
any evidence of COVID-19 virus in pregnancy products
and infants of infected mothers [33]. Schwartz and
Graham believe that in some cases, a viral infection
can be transmitted to the baby through the birth
canal or during lactation, but these mechanisms are
very unusual in the case of viral infections [34]. Cao
et al. conclude that there is no information about the
mother-to-fetus/infant transmission of the virus during
the perinatal period and vaginal delivery, and also no
evidence of intrauterine transmission has been
reported so far [8]. Additionally, other investigators
have not confirmed vertical transmission of the virus
from an infected mother to the newborns [19,35–37].
Zhang et al. using data of 81,026 confirmed COVID-19
cases in China, identified 4 nucleic acid-confirmed
neonatal infections. At the time of disease onset, two
newborns were at isolation and the other two were
not isolated. The authors’ findings support intrauterine
transmission potential [30].
In a study done by Zhu et al. they found that nine
babies born to infected mothers with COVID-19 had
negative pharyngeal swabs tested by real-time
reverse-transcription polymerase chain reaction (rRTPCR), which supports the notion that the SARS-CoV-2
Coronavirus cannot be transmitted vertically from
mother to baby. Nevertheless, they recommended
that due to the limited sample size of their study, further studies are warranted to achieve a strong conclusion about vertical transmission of SARS-CoV-2. In this
study, there was fetal distress in 6 infants. For this reason, the researchers assumed that this event may be
related to COVID-19. So, before the childbearing of an
infected mother, gynecologists should ask a neonatal
specialist who is an expert in resuscitation, be ready in
the delivery room. They reported one neonatal death
in their analysis but the baby’s throat swab obtained
nine days after delivery, was negative for COVID-19
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[22]. The youngest baby has been infected with
COVID-19 thirty hours after birth. The baby was born
on 2 February 2020 at a hospital in Wuhan, China,
from a mother who was ill, and on February 5th, it
was reported that the baby had confirmed COVID19infection. The baby’s vital signs were stable, without
fever or cough, but he had shortness of breath, abnormal liver tests, and abnormal radiography [34].
In nine women at Zhongnan Hospital in China,
samples of whole blood, serum, oral swabs, urine, and
feces were tested. Additionally, milk of all 9 mothers
was tested for associated RNA of SARS-CoV-2. All
aforementioned tests were reported negative.
Similarly, at Tongji Hospital, samples of two newborns
and the breast milk of their infected mothers were
tested and reported to be negative for RNA of SARSCoV-2 [34].
In a retrospective study, Zhang et al. compared the
neonatal outcomes of two groups of mothers, including 16 mothers with confirmed COVID-19 infection
and 45 healthy mothers. All of whom gave birth at
36 weeks by cesarean section. None of the babies
were infected after birth and there was no significant
difference between newborns in terms of neonatal distress, meconium in amniotic fluid, and neonatal
asphyxia [30]. In another study, Yin et al. could not
detect the presence of SARS-CoV-2 in amniotic fluid,
placenta, neonatal throat, and anal swab and breast
milk samples of 31 infected mothers [16].
Chen et al. in a study of swabs from the throats of
three infants whose mothers infected with COVID-19
at the end of pregnancy, found that all samples were
negative for the nucleic acid of COVID-19. No pathological findings were found in the placenta of these
infants and they were negative for the nucleic acid of
SARS-CoV-2 [11]. In a recent report from outcomes of
13 newborns born to infected mothers, 1 of 9 samples
of stool and 1 from 3 samples of breast milk was positive for Coronavirus nucleic acid [38].
In Iran, there is a case report of a 15-day-old infant
infected with COVID-19. The baby had a fever, sweating, respiratory problems, and motility, but no cough
or runny nose and gastrointestinal symptoms were
detected. The baby was under care in the newborn
intensive care unit (NICU). Her parents had recently
cough, fever, and sweating. The infant was tested
positive for COVID-19. The baby was discharged 6 days
after hospitalization, with good condition. The
researchers suggested that because of various clinical
and laboratory symptoms that infants may have, it is
logical that we do rt-PCR for infants with symptoms of
COVID-19 infection [39].

According to a case report published in the Journal
of American Medical Association (JAMA) [40] a baby
was born on 22 February 2020, to a mother with a
cesarean section at a hospital in Wuhan, China.
Maternal vaginal discharge was negative for
Coronavirus. The baby had no abnormal symptoms
and his lung CT images and rt-PCR tests of pharyngeal
swabs were negative, but the baby had a high level of
Immunoglobulin G (IgG) and Immunoglobulin G (IgM)
between 2 h and 16 days after birth. The baby was isolated in a negative pressure room and was discharged
from hospital on March 18. The authors concluded
that elevated levels of IgG in the baby may be a sign
of maternal or neonatal infection, and high levels of
IgM and laboratory evidence of inflammation and
abnormal liver tests may indicate that the baby was
infected with COVID-19 in the mother’s womb. The
limitations of this study are that only one case was
examined and the placenta and amniotic fluid were
not examined [40]. Lackey et al. emphasized that IgM
antibodies present in the serum of SARS-CoV-2 negative infants cannot cross the placental barrier. Thus,
these findings indicate that the baby had an infection
(and the production of these antibodies) in the uterus [41].

Appropriate method and time of delivery in
women with COVID-19
Mode of childbearing is determined by routine midwifery indications and there is no benefit in performing cesarean section for all [10,32,42]. However, most
studies have reported that cesarean section is performed for infected pregnant women with COVID-19
[11,12,22,30,32,43,44]. Wu et al. in their case series of
13 Chinese pregnant women with COVID-19 concluded that a vaginal delivery may be a safe delivery
option because in all women vaginal secretion specimens were negative for the novel Coronavirus [38].
Regarding the time of delivery for women with
COVID-19, it is stated that the virus is not an indication for childbirth, but in the case of severe maternal
symptoms, termination of pregnancy is recommended
[19,42]. If the mother’s symptoms are severe and the
gestational age is less than 23 to 24 weeks–when the
fetus is not yet viable–termination of pregnancy is recommended [19,42]. If the fetal age is between 26 and
34 weeks, the time of delivery will be determined by
the condition of the mother and fetus. If the fetus is
34 weeks or older, due to a high chance of survival,
late preterm delivery is possible [42]. Thus, it is logical
for women who are pregnant in the third trimester, to
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delay childbirth [32]. If the mother’s symptoms are
mild, the pregnancy could be closely monitored and
continued until the term [42].

Umbilical cord clamping and skin to skin contact
The International Society of Ultrasound in Obstetrics &
Gynecology (ISUOG) and existing evidence recommend that the umbilical cord should be clamped
quickly to reduce the risk of vertical transmission
[17,29] and the infant should be sent to a resuscitation
facility for evaluation by a pediatrician [17].
Nevertheless, the Royal College of Obstetricians and
Gynecologists (RCOG) recommend that umbilical cord
clamping may be done routinely because during vaginal delivery it is unlikely that the risk of vertical transmission change with one more minute of perfusion
through the placenta. Most likely, COVID-19 transmission occurs in the postpartum period and through
normal routes [45]. Additionally, studies from the USA
maintained that delayed umbilical cord clamping
(DCC) does not increase the risk of vertical transmission, and therefore, it should be performed for at least
60 s if the baby is vigorous. However, in some centers,
immediate cord clamping is preferred for example
when the mother is symptomatic (fever, cough, and
other respiratory symptoms), to minimize exposure in
the delivery room [10].
Concerning the skin-to-skin contact, WHO recommends that mothers or infants with suspected, probable, or confirmed COVID-19 can remain together with
skin-to-skin contact, especially immediately after birth
during the initiation of breastfeeding [10,46].
Nevertheless, some experts do not recommend skinto-skin contact between mothers and newborns at the
time of COVID-19 infection [47] since they believe that
the transmission of SARS-Cov-2 through the skin-toskin contact cannot be ruled out. Taken together, it
seems that shared decision-making with the parents
before delivery regarding the potential risks and benefits of skin-to-skin contact is the best option [10].
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pain. A number of infants may also develop acute
respiratory distress syndrome [4,8]. Other symptoms
are lethargy and feeding intolerance [10].
In infected newborns, the initial symptoms may be
fever, cough, or diarrhea. Although vertical transmission of COVID-19 has not confirmed yet, the perinatal
infection may cause premature labor, respiratory distress, thrombocytopenia accompanied by abnormal
liver function, and even death [22]. For instance, the
late-onset respiratory distress has been described in
several infants 1–3 weeks after birth and/or discharge
from the hospital [10].

Confirmation of infection in a suspected
newborn/infant
In infected mothers, the infant should be tested at or
beyond 24 h after birth [10]. Separate swabs of the
nasopharynx, oropharynx, and rectum are recommended. A second test 24 h later may be valuable for
confirmation [10].
Infants who infected with COVID-19 tend to have
mild clinical symptoms and their CT imaging findings
are not as typical as adults’, therefore, diagnosis of
COVID-19 should be made based on three major findings including CT imaging, epidemiological history,
and nucleic acid detection [48].
According to Shah et al. classification system and
case definition for SARS-CoV-2 infection, congenital
infection in alive born newborn will be confirmed in
the following conditions: (i) when there is detection of
the virus by PCR in umbilical cord blood or neonatal
blood collected within first 12 h of birth or amniotic
fluid collected prior to rupture of membrane; (ii)
Neonatal infection acquired intrapartum can be confirmed when there is detection of the virus by rt-PCR
in nasopharyngeal swab at birth and 24–48 h of age;
(iii) neonatal infection acquired postpartum can be
confirmed when there is detection of the virus by rtPCR in nasopharyngeal/rectal swab at 48 h of birth
in a newborn whose respiratory sample tested negative by rt-PCR at birth [49].

Clinical manifestations of infected infants
Newborns might catch SARS-Cov-2 through close contact with infected patients or asymptomatic virus carriers. The disease might have an insidious onset and
be nonspecific [33]. For example, in preterm infants’
symptoms may be nonspecific and include instability
of body temperature, gastrointestinal symptoms, and
respiratory problems including fever, cough, runny
nose, nausea and vomiting, diarrhea, and abdominal

Instructions for infant’s care and how to feed
her/him
The American College of Obstetricians and
Gynecologists (ACOG) and the US CDC recommend
the separation of mother and baby in separate rooms
if the mother is infected or suspected to have infection [23,50]. CDC temporary guidelines for breastfeeding in infected or suspected mothers also state that if
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the mother wants to breastfeed the baby, she should
be milked by hand or pump [51]. The WHO recommends that women with COVID-19 can feed their
baby directly by her breast or she could feed her baby
by expressed milk or using donor milk [52].
The Chinese Expert Consensus believes that all suspected or infected infants (including babies who are
born to infected/suspected pregnant women) should
be admitted to the NICU [29]. In general, all infants
before admission to the NICU should be screened for
COVID-19 by collecting clinical and non-clinical history
from their parents. The high-risk infants should be isolated at least 14 days in a separate room. Infants are
more vulnerable to infection due to their still-developing immune system, so standard precautions should
be taken in the care of infants until their status is
determined [29]. National Health Commission of the
People’s Republic of China [53] recommends that
babies born to infected or suspected mothers with
COVID-19 should be kept isolated in a unit designed
to care for them up to 14 days. They also emphasized that mothers must not feed their babies by
breast milk until their recovery [53].
According to the instructions of the Ministry of
Health and Medical Education of Iran, the COVID-19
suspicious mother is not prohibited from breastfeeding, if the mother’s diagnosis is conclusive the baby
should be quarantined for 2 weeks and the mother
could feed the baby by her breast milk or formula or
donor milk, depending on mother’s condition [54].
According to temporary instructions from the
International Society of Ultrasound in Obstetrics &
Gynecology (ISUOG), if the mother is very ill, separation of mother and baby is the best option, and milk
expression should be done to maintain milk production. If the mother is asymptomatic and has a mild illness, breastfeeding, and rooming-in can be done with
the help of the mother and health care provider [17].
RCOG has a less strict guideline and recommends that
infected or suspected mothers do not need to be separated from their baby and they can be kept together
during the postpartum time. The mother can express
her milk and then feed the infant through a caregiver
[45]. The USA experts classify the relationship between
mother and baby and infant nutrition, based on parental preference, the number of hospitalized patients,
and the economic status of the community [10]. In
general, they have introduced three options to parents
and health care providers. These options range from
formula feeding and expressed breast milk to direct
breastfeeding [10]. According to Italian Society of
Neonatology (SIN) and Union of European Neonatal &

Perinatal Societies (UENPS), if an infected or suspected
mother is asymptomatic at delivery, rooming-in is feasible and direct breastfeeding is allowed but if the
mother is too sick to care for the newborn, the newborn has to be managed separately and fed fresh
expressed breast milk [55]. More details on these
guidelines are given in Table 1.

Bathing the baby
An early bath to minimize exposure can be considered
in stable term newborn infants born to a mother with
suspected or confirmed COVID-19 infection [10].

Baby discharge criteria from hospital
If the infant is positive but asymptomatic, he/she can
be discharged but may need to be quarantined at
home. If the infant is negative and asymptomatic, he/
she can be discharged to be cared for by a noninfected, asymptomatic caregiver [56]. If the infant is
positive and symptomatic, the temperature should be
normal for more than three days; respiratory symptoms and radiographic findings should be shown significant improvement; and nasal, pharyngeal, and
sputum swabs, should be negative for COVID-19 for
two consecutive days (i.e. 24 h apart) [57].

The impact of isolation on the maternal mental
well-being
Because the separation of the infected mother from
the baby and the lack of breastfeeding can lead to
the deprivation of the mother and baby from
“bonding,” resulting in more maternal stress during
the postpartum time, it is recommended that the
health providers, in addition to helping the mothers’
physical health, also consider the mothers’ mental
health and facilitate mental supports during this
health crisis [17].

Discussion and conclusion
The possibility of mother-to-fetus transmission of
SARS-CoV-2 is currently a highly debated concept in
perinatal medicine community [26,49]. Concerns about
the effect of COVID-19 on the fetus and the infant are
important issues in the field of reproductive health
and fetal-maternal medicine. According to the literature, the first and safe option to diagnose COVID-19 is
a chest CT scan because so far the dose of radiation
emitted to the fetus from CT is very low and has no
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Table 1. Infant care and breastfeeding in an infected or suspected mother.
Source
CDC/ACOG

Recommendation





WHO




Chinese expert consensus












National Health Commission
of the People’s Republic
of China
Iranian Ministry of Health and
Medical Education










Temporary instructions
from ISUOG



The CDC & ACOG recommend the separation of mother and baby in separate rooms if the mother is infected
or suspected to have COVID-19 infection. CDC also recommends that an infected mother can transmit the virus
through respiratory droplets during breastfeeding therefore, health care providers should consider temporarily
separation of the baby from the infected or suspected mother (in a separate room). No one should meet the
baby except her healthy parents and a caregiver.
If the separation of mother and baby is not possible, there should be a physical barrier between mother and
baby and there should be a distance of at least 6 feet (1.8 meters) between them. If there is no person to take
care of the baby, the mother can take care of the baby herself by washing her hands and wearing a mask.a
The guideline also emphasizes that breast milk is the best source of nutrition for the baby. In a mother with
COVID-19 or a mother who has symptoms of respiratory infection, if breastfeeding is chosen, she should wash
her hands before touching her baby and wearing a mask if possible. If the mother wants to breastfeed the
baby, she should be milked by hand or pump. The mother should wash her hands before touching the pump
or bottle components and follow the instructions on how to clean the pump after each use.b
WHO recommends that women with COVID-19 can breastfeed their baby (directly) if they wish, but they
should follow a respiratory hygiene etiquette, such as wearing a mask, wash their hands before and after
touching the baby, and clean and disinfect the surfaces that they touch.
If a mother is reluctant to breastfeed her baby due to COVID-19 or any other unprecedented problems, she
should try another way to breastfeed her baby, including milk expression or using donor milk.c
Babies can get the disease through close contact with an infected person or from carriers. The onset of the
disease in infants may be insidious and nonspecific.
There should be at least one of the following criteria for the diagnosis of infection in infants: At least one of
the clinical symptoms, including:
i. Temperature instability
ii. Hypoactivity
iii. Poor nutrition or tachypnea
iv. Abnormal findings on chest radiography
Being at risk of infection due to close contact with a family member or caregiver or other people who are
suspected of having an infection or have been diagnosed with an infection, including people with pneumonia
of unknown cause, or people who have worked with animals or had close contact with animals, or people who
live in areas where the disease has been epidemic or have traveled to these areas recently.
All suspected or confirmed infants should be admitted to the NICU. In general, all infants before admission to
the NICU should be screened for COVID-19 by taking a history from their parents, and high-risk infants should
be isolated at least 14 days in a separate room. At the time of admission if the baby is very suspicious, or
within 14 days of isolation, shows signs of illness, he should be referred to the center of COVID-19 infection.
Infants are more vulnerable to infection due to a lack of immune system development, so standard precautions
should be taken in the care of infants until their status is determined. This includes marking the entrance door
of the ward, careful hand and respiratory hygiene, daily cleaning, and disinfection of the environment and
preparation of gloves, masks, and goggles for all medical staff, additional precautionary measures including
dedicated equipment for the patient; limit parental visits; changing clothes and gloves after doing any
procedure and opening the window regularly to change the weather
Waste produced from medical works should be collected in a two-layer infectious waste bag and should be
soaked in chlorine-containing preparation for at least 10 minutes, then dispose of in the same way as medical
infectious waste. Disinfection of the patient’s room should preferably be done using hydrogen peroxide
automation or chlorine spray.d
According to the National Health Committee of China, babies born to mothers with or suspected of having
COVID- 19 should be kept in a unit designed to care for them up to 14 days, isolated and not breastfed after
birth, and as long as the mother is suspected or infected, close contact with the moth is forbidden.e
According to the instructions of the Iranian Ministry of Health and Medical Education, if there is a person in
the family who is infected or suspected of having COVID-19 infection, a separate room should be provided for
the baby if possible, and if this is not possible, the baby should be kept at least two meters away. If this
person is the baby’s mother, the mother and baby can be together, but the principles of home quarantine
hygiene must be followed. If the mother is suspicious of having COVID-19, as long as she follows hygienic
principles (hand washing and masking), breastfeeding is not prohibited.
If the mother’s diagnosis is conclusive and the mother is in good condition and has not been hospitalized, the
baby should be quarantined for 2 weeks and the mother could feed the baby by her breast milk.
If a baby is born to a suspected or infected mother and needs hospital care, for example, due to prematurity
or respiratory distress, the baby should be transferred to the neonatal intensive care unit. But if it is not ill, it
should be quarantined at home for 14 days and a room or at least a separate space should be allocated to
him. Skin-to-skin contact with the baby should be minimized and kissing should be avoided.
In hospitalized mothers, if the mother is not in good condition, the baby should be fed with a formula or a
milk bank. But if the mother’s general condition is good, breastfeeding is advisable.
At the hospital, if a baby is born to an infected mother, the baby is considered suspicious and must be
quarantined for two weeks. If the mother is suspicious, the baby should be temporarily kept in another room,
and if this is not possible, the baby can be kept in a common room but at least two meters away from the
mother, and mother and baby must be separated from each other through a curtain that extends from the
ceiling to the floor.f
There is insufficient evidence on the safety of breastfeeding (ie, recommending breastfeeding) and, on the one
hand, the need for separation mother and baby:
i. If the mother is very ill, separation of mother and baby is the best option, and milk expression should be
done to maintain milk production
ii. If the mother is asymptomatic and has a mild illness, breastfeeding and rooming-in can be done with the
help of the mother and health care provider.

(continued)

8

S. SHAHBAZI SIGHALDEH AND M. E. KALAN

Table 1. Continued.
Source


Royal College of Obstetricians
and Gynecologists (RCOG)




American authors




Italian Society of Neonatology
(SIN) and Union of
European Neonatal &
Perinatal Societies (UENPS)




Recommendation
Also, if it is not possible to separate the mother and baby due to lack of facilities, the mother and baby can be
kept in the same room. Because the virus may be transmitted by airborne droplets more than breast milk,
breastfeeding mothers should wash their hands thoroughly and use three-ply surgical masks before contact the
baby. If the mother and baby are in the same room, the baby’s cut should be kept at least two meters away
from the mother’s bed and a physical barrier such as a curtain should be used.g
According to the RCOG:
i. An infected or suspected mother does not need to be separated from the baby and they can be kept
together during the postpartum time
ii. The mother can express her milk and then feed the infant with the help of a caregiver.
Also, the neonatologist should discuss the benefits and disadvantages of rooming-in as well as breastfeeding
with the infant family.h
For infected mothers whose infants are still negative or pending a test for COVID-19, three options can
be considered:
i. The infant can receive formula or donor milk. The mother can pump her milk until she is asymptomatic with
two negative tests for COVID-19 at least 24-hour apart
ii. The mother has to wear a mask, wash her breast with soap, and then express breast milk. A healthy family
member or a nurse can feed the expressed milk to the baby in a separate room. This approach continues
until the mother meets the same criteria as in the First option.
iii. The mother can wear a surgical mask, wash her hands and breasts with soap and water, and breastfeed the
baby. These precautions continue until the fever of mother and other symptoms subside and has two
negative tests for COVID-19 at least 24-hour apart.
The first option is suitable for resource-rich settings with low patient volume, the second is suitable when
resources are starting to fall with modest patient volume, and the last option for the poor and underdeveloped
settings with a large influx of patients.i
If an infected or suspected mother is asymptomatic at delivery, rooming-in is feasible and direct breastfeeding
is allowed, under strict measures of infection control.
When a mother is too sick to care for the newborn, the newborn has to be managed separately and fed
freshly expressed breast milk. There is no need to pasteurize breast milk because human milk is not believed
to be a vehicle of coronavirus.j

a

WHO [52]; bWHO [3]; cWHO [1]; dWang L et al. [29]; eNational Health Commission of the People’s Republic of China [53]; fIranian Scientific Breastfeeding
Promotion Society [54]; gPoon et al. [17]; hRCOG [45]; iChandrasekharan et al. [10]; jDavanzo et al. [63].

harmful effects. The neonatal consequences of mothers with COVID-19 infection have been reported to be
the same as those of non-infected mothers. For this
reason, researchers believe that compared to acute
respiratory syndrome Coronavirus (SARS-CoV) and
Middle East respiratory syndrome Coronavirus (MERSCoV), which were associated with serious maternal
and neonatal consequences, SARS-CoV-2 is not considered a high-risk virus for mother and baby [58] and
the majority of newborns born to mothers with SARSCoV-2 infection either do not become infected or
exhibit mild-to-moderate symptoms at birth [49]. As of
this writing, in COVID-19 related studies, there have
been no reports of infant and fetal deaths.
Additionally, amniotic fluid, whole blood, umbilical
cord, placenta, oral swabs, serum, urine, and infant
stools are reported negative for the Coronavirus.
In discussed studies, the Apgar score of infants of
infected mothers was reported to be normal after
birth. However, there are a few reports of respiratory
distress and acute respiratory distress syndrome
(ARDS) in infants of infected mothers. Therefore, performing this quick assessment on a baby at 1 and
5 min after birth can help to identify the typical and
potential symptoms of COVID-19.
Although some experts have ruled out the risk of
intrauterine transmission, others have been cautious

about this risk [41]. They argue that although negative
samples of pregnancy products and newborns make
the possibility of intrauterine transmission small, the
report of viral antibodies in an infant’s blood whose
rt-PCR test was negative and some cases of fetal distress in some infants of infected mothers, make it
hard draw a definite conclusion in this regard.
Although the possibility of prenatal transmission
for COVID-19 has been ruled out previously [8,34],
a study done by Nie and colleagues among 26 newborns, reported perinatal transmission in one
newborn. They emphasized that this case could not
be a case of vertical transmission because the cord
blood and placental samples were both negative for
SARS-CoV-2 [58]. Therefore, both intrauterine transmission and perinatal transmission of the virus both
are still challenging and ambiguous, and more studies are needed to draw definitive conclusions about
them. Simultaneously, what researchers have more
clearly understood is the significant risk of motherto-baby virus transmission after birth. It means
babies who are born to mothers with confirmed
COVID-19 can acquire the infection post-delivery
[59]. For this reason, breastfeeding has been banned
despite the lack of Coronavirus in the milk of
infected mothers. In addition to the prohibition of
breastfeeding, it is recommended that the baby be
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 1, 461 citations identified from electronic
literature search and screened

 52 potentially relevant articles retrieved for
study (49 full text and 3 abstracts)

 9 Potential guidelines
retrieved from national
and international
guidelines and 5 potential
reports retrieved from
other sources (gray
literature)

 1409 citations were excluded due
to i) being not a scientific report,
ii) irrelevant population, iii)
irrelevant to the purpose of this
study, and, iv) duplications.

2 articles were deleted because
their abstract and full text were
not in English language

 64 reports included in this review

Figure 1. Study flowchart.

Figure 2. Syringe breast pump. Source: World Health
Organization; UNICEF 1993; [cited 2020 Jun 9]. Available from:
https://www.who.int/maternal_child_adolescent/documents/
who_cdr_93_3/en/

isolated and kept away from the mother after birth
for about two weeks.
Since micro-droplets can transmit the virus to the
newborn, advising mothers to be separate from their
baby sounds perfectly reasonable. According to the

scientific community (e.g. WHO, SIN, ISOUG), after two
weeks of isolation if the infected mother is not ill and
tends to breastfeed, she can feed her baby directly by
her breast milk. Hand washing before touching the
baby and wearing a face mask during breastfeeding is
the most effective preventive measures against
COVID-19 [55]. Formula feeding can be applicable
given that feeding babies with breast milk is almost
impossible. Although scientists suggest that feeding
the baby by mother’s breast milk could be an option
if parents and providers accept the risk of transmission, they strongly emphasized that in resource-rich
setting formula feeding is preferable [10].
Regardless of the setting in which the mother is
hospitalized, the preference of formula feeding may
be somewhat understandable. Because in mothers
who are being treated with antiviral drugs the safety
of breast milk remains unknown [10]. Since one of the
three samples of breast milk tested in the study of Wu
et al. was positive for Coronavirus nucleic acid, they
recommended that breast milk safety be investigated
in further studies [38]. On the other hand, it is
believed that in Coronavirus pandemic breastfeeding
should be promoted especially when there is a shortage of formula [59] and in order to prevent emotional
trauma for the nursing baby and enhancing their
immune responses by the specific secretory IgA antibodies producing in the milk of infected mothers [60].
According to WHO, if a woman wants to keep her
milk supply, she should express at least every 3 h and
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if it seems to be decreasing after a few weeks, she
should express every 30–60 min and at least every 3 h
during the night. Another important recommendation
of WHO is that a woman should express her breast
milk because the breast will be easily hurt if another
person tries to express it [61]. This organization also
has recommended that syringe pumps are more efficient than rubber bulb pumps, and it is easier to clean
and to sterilize (Figure 2). The disadvantages of rubber
bulb pumps are that they can easily carry infection,
which is especially dangerous if more than one
woman uses the same pump. For sanitizing cups or
other appliances, in normal condition, WHO recommends pouring boiling water into them for a few
minutes [61]. But during COVID-19 pandemic, Marinelli
and Lawrence suggest the disinfecting of milk containers with viricidal agents made from sodium hypochlorite mainly for protecting from spreading the virus by
the surfaces of these containers [62]. There is no need
to pasteurize breast milk because human milk is considered safe, not a vehicle of Coronavirus [63].
According to a Cochrane study initiation of milk
expression sooner after birth when not feeding at the
breast, relaxation, massage, warming the breasts, hand
expression, and lower cost pumps may be as effective,
or more effective, than large electric pumps [64]. These
statements tell us that breastfeeding requires a lot of
patience, skills, and motivation from mother. Thus, if the
mother is not skilled enough or the mother’s general
condition is not good enough to express her milk herself (according to WHO recommendation), another nutritional method, i.e. formula will be chosen. In this
regard, Davanzo stated that the practice of routine separation of the newborn infant from her mother, can
damage the mother–baby relationship and the re-beginning of breastfeeding will be difficult [55].
In addition to the mother’s inability to start or continue breast milk expression, she may also be concerned about the safety of her milk. Therefore, it is
important to reassure the mother that her milk is safe.
Interestingly, almost a decade ago, veterinary medicine investigators have reported the detection of
some antibodies against some viruses such as
Coronavirus in colostrum of non-immunized, naturally
infected cows [65]. The authors claimed that these
antibodies can develop passive immunity against
Coronavirus in their suckling calves [65]. Also, Davanzo
believes that in the light of limited scientific evidence
breast milk cannot be considered a vehicle of
Coronavirus infection, but it contains some specific
antibodies that can help the baby become stronger
against the virus [54]. During the SARS outbreak, at

130 days after illness onset, antibodies of SARS-CoV
were detected in the breast milk of a pregnant
woman, with no evidence of virus [62,66]. This highlights the importance of further research on human
breast milk antibodies that can have protective roles
and lead to passive immunity in the infant of infected
mothers. Another important point is the possibility of
respiratory distress in preterm or term babies of pregnant women who have a serious or critical infection.
Thus, all pregnant women with COVID-19 infection
should be admitted to the hospitals that are equipped
with NICU.

Recommendation
 Breastfeeding can be encouraged in infected or
suspected mothers. This should be based on
informed decision making and in full compliance
with measures of infection control. If there are concerns about compliance with preventive measures,
or the parents are worried about the safety of the
milk, bottle-feeding will be a better option.
 Parents should be taught that if a baby is in close
contact with a sick person, such as his mother, the
risk of infection is very high, so both the infected
mother and other suspected or infected people
should be kept away. Also, no one should visit the
baby except the healthy parent and caregiver with
personal protective equipment (PPE).
 The mother should be trained on how to breastfeed (with all three methods of hand, syringe, or
pump). In the first few times of breast expression,
the trainer should observe mother to make sure
that the milk is properly expressed.
 Mother and other family members should be advised
to disinfect the pump or other milk containers with
agents made from sodium hypochlorite.
 Before discharge, mothers should be taught about
conditions that can help the breast milk to come
out better during breast expression, including
relaxation, massage, and warming the breasts.
 If parents decide to consume formula because of
reasons such as fear of milk safety, teach them
how to clean the bottle well.
 Because the baby does not breastfeed, milk stasis
can lead to problems such as full breast, breast
tenderness, and inflammation of the breast. The
symptoms of these problems should be explained
to the mother. Additionally, the suitable interval
between breast expression and how to disinfect
the equipment, such as a bottle or pump, after
each feeding should be taught to the parents.
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 The person who is going to take care of the baby
during two weeks of isolation should be taught
how to breastfeed the baby and the principles of
personal hygiene should be emphasized, including
regular hand washing and PPE.
 Because the symptoms of the onset of infection in
the baby may be nonspecific or gastrointestinal
disorders, the first symptoms may be, so these
symptoms should be taught to caregivers and
parents and they should be warned that when
they see these symptoms, the baby should be
taken immediately to an emergency room.
 Using appropriate masks by parents and the child’s
caregiver, the type of gloves, and the correct way
to wash the hands should be given high priority.
 Follow up on the detection of initial symptoms of
infection after discharge by phone calls or virtual networks.
 Parents should be informed about national screening, vaccination, and routine visits programs during
the COVID-19 pandemic.
 Researchers should introduce ways to help the
mothers do breast expression more effectively and
encourage them to continue to do so until the end
of the baby’s isolation period.
 It is critical to update national/international guidelines to offer a practical guide to the health care
providers, physicians, and parents.
 Finally, further studies are strongly recommended
to assess the safety of breast milk.
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